Javascript must be enabled to continue!
A Randomized Controlled Trial to Compare the Efficacy of Single Mega Dose Vitamin D Therapy with Standard Daily Dose Vitamin D Therapy in Vitamin D Deficient Critically Ill Children
View through CrossRef
Introduction: The prevalence of vitamin D deficiency has been reported to be very high (up to 50%) in criticallyill children admitted in Paediatric ICU, and vitamin D deficiency has been associated with increased mortality,increased length of Paediatric ICU and hospital stay. But the impact of supplementation of vitamin D in thesechildren on the clinical outcome is not very clear.Study Objectives: Primary Objective: To compare the efficacy of single mega dose vitamin D therapy withstandard daily dose vitamin D therapy in vitamin D deficient critically ill children.Secondary Objective: To assess the prevalence of vitamin D deficiency in critically ill children in a tertiary carecentre.Methodology: A study population of 50 children meeting inclusion criteria were enrolled in our study. All thesubjects admitted to our Paediatric ICU were subjected to a detailed history and examination. Vitamin D levelswere sent at admission and children with vitamin D deficiency (< 20ng/dl) were taken as study subjects andrandomized into two groups. One group received single mega dose vitamin D therapy, and the second groupreceived standard daily dose vitamin D therapy. These children were followed up until their Paediatric ICU stayor death. The impact of supplementation was compared among both the groups in terms of length of PaediatricICU stay and mortality.Results: The mean length of Paediatric ICU stay among children receiving a single mega dose vitamin D therapywas 5.04 days compared to 3.56 days among children receiving standard-dose vitamin D therapy (p-value 0.337),suggesting no significant difference in the length of Paediatric ICU stay among the study subjects of both groups.There was no mortality among these study subjects. The prevalence of vitamin D deficiency in the study groupwas 55.6%.Conclusion: Supplementation of a single mega dose of vitamin D compared to the standard dose of vitamin D hasno advantage on the clinical outcome of Vitamin D deficient critically ill children in terms of length of PaediatricICU stay and mortality.
Institute of Medico-legal Publications Private Limited
Title: A Randomized Controlled Trial to Compare the Efficacy of Single Mega Dose Vitamin D Therapy with Standard Daily Dose Vitamin D Therapy in Vitamin D Deficient Critically Ill Children
Description:
Introduction: The prevalence of vitamin D deficiency has been reported to be very high (up to 50%) in criticallyill children admitted in Paediatric ICU, and vitamin D deficiency has been associated with increased mortality,increased length of Paediatric ICU and hospital stay.
But the impact of supplementation of vitamin D in thesechildren on the clinical outcome is not very clear.
Study Objectives: Primary Objective: To compare the efficacy of single mega dose vitamin D therapy withstandard daily dose vitamin D therapy in vitamin D deficient critically ill children.
Secondary Objective: To assess the prevalence of vitamin D deficiency in critically ill children in a tertiary carecentre.
Methodology: A study population of 50 children meeting inclusion criteria were enrolled in our study.
All thesubjects admitted to our Paediatric ICU were subjected to a detailed history and examination.
Vitamin D levelswere sent at admission and children with vitamin D deficiency (< 20ng/dl) were taken as study subjects andrandomized into two groups.
One group received single mega dose vitamin D therapy, and the second groupreceived standard daily dose vitamin D therapy.
These children were followed up until their Paediatric ICU stayor death.
The impact of supplementation was compared among both the groups in terms of length of PaediatricICU stay and mortality.
Results: The mean length of Paediatric ICU stay among children receiving a single mega dose vitamin D therapywas 5.
04 days compared to 3.
56 days among children receiving standard-dose vitamin D therapy (p-value 0.
337),suggesting no significant difference in the length of Paediatric ICU stay among the study subjects of both groups.
There was no mortality among these study subjects.
The prevalence of vitamin D deficiency in the study groupwas 55.
6%.
Conclusion: Supplementation of a single mega dose of vitamin D compared to the standard dose of vitamin D hasno advantage on the clinical outcome of Vitamin D deficient critically ill children in terms of length of PaediatricICU stay and mortality.
Related Results
Importance of vitamin D in critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis
Importance of vitamin D in critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis
SummaryBackgroundCritical care and sepsis remain high priority concerns in children. Observational studies report high prevalence of vitamin D deficiency and present mixed results ...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Nutritional Deficiencies and Features of Nutritional Provision in Primary School Children
Nutritional Deficiencies and Features of Nutritional Provision in Primary School Children
Introduction. The nutrition of primary school children does not always meet modern nutritional standards. The frequency of nutritional deficiencies, including calcium and vitamin D...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...
Cochrane review: Vitamin A for treating measles in children
Cochrane review: Vitamin A for treating measles in children
AbstractBackgroundMeasles is a major cause of childhood morbidity and mortality. Vitamin A deficiency is a recognized risk factor for severe measles infections. The World Health Or...
Optimizing Hydroxyurea Dosing in Sickle Cell Anemia: The Uganda MTD Study
Optimizing Hydroxyurea Dosing in Sickle Cell Anemia: The Uganda MTD Study
Introduction. Hydroxyurea treatment has proven safety, feasibility, and efficacy for children with sickle cell anemia living in sub-Saharan Africa. Even in malaria endemic regions,...
<span class="word">Successful <span class="word"><span class="changedDisabled">Replacement <span class="word"><span class="changedDisabled">Therapy <span class="word"><span class="changedDisabled">After <span c
<span class="word">Successful <span class="word"><span class="changedDisabled">Replacement <span class="word"><span class="changedDisabled">Therapy <span class="word"><span class="changedDisabled">After <span c
Background. Vitamin D has recognized immunomodulatory, anti-proliferative, and differentiation-regulating effects primarily mediated through its genomic effects via the vitamin D r...

